1. Home
  2. LSF vs ANVS Comparison

LSF vs ANVS Comparison

Compare LSF & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSF
  • ANVS
  • Stock Information
  • Founded
  • LSF 2015
  • ANVS 2008
  • Country
  • LSF United States
  • ANVS United States
  • Employees
  • LSF N/A
  • ANVS N/A
  • Industry
  • LSF Packaged Foods
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSF Consumer Staples
  • ANVS Health Care
  • Exchange
  • LSF Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • LSF 65.5M
  • ANVS 55.5M
  • IPO Year
  • LSF 2020
  • ANVS 2020
  • Fundamental
  • Price
  • LSF $7.09
  • ANVS $2.69
  • Analyst Decision
  • LSF Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • LSF 2
  • ANVS 4
  • Target Price
  • LSF $12.00
  • ANVS $18.00
  • AVG Volume (30 Days)
  • LSF 32.0K
  • ANVS 326.7K
  • Earning Date
  • LSF 08-06-2025
  • ANVS 08-14-2025
  • Dividend Yield
  • LSF N/A
  • ANVS N/A
  • EPS Growth
  • LSF N/A
  • ANVS N/A
  • EPS
  • LSF N/A
  • ANVS N/A
  • Revenue
  • LSF $45,040,358.00
  • ANVS N/A
  • Revenue This Year
  • LSF $23.40
  • ANVS N/A
  • Revenue Next Year
  • LSF $20.11
  • ANVS N/A
  • P/E Ratio
  • LSF N/A
  • ANVS N/A
  • Revenue Growth
  • LSF 25.04
  • ANVS N/A
  • 52 Week Low
  • LSF $3.40
  • ANVS $1.11
  • 52 Week High
  • LSF $10.90
  • ANVS $11.29
  • Technical
  • Relative Strength Index (RSI)
  • LSF 55.32
  • ANVS 57.48
  • Support Level
  • LSF $7.06
  • ANVS $2.63
  • Resistance Level
  • LSF $7.80
  • ANVS $3.00
  • Average True Range (ATR)
  • LSF 0.38
  • ANVS 0.20
  • MACD
  • LSF 0.02
  • ANVS 0.02
  • Stochastic Oscillator
  • LSF 33.64
  • ANVS 75.21

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: